Among Older Adults, a Longer Interval Between Pfizer Doses May Increase Antibody Response
New research from the United Kingdom finds that when older adults waited 12 weeks before receiving their second dose of the Pfizer COVID-19 vaccine, the resultant level of antibodies produced was 3.5 times higher than among those who…